Monopar Therapeutics (MNPR) director granted 1,284 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Monopar Therapeutics director Nicole Sweeny received a grant of stock options, acquiring rights to 1,284 shares of common stock. The options have an exercise price of $87.68 per share and expire on June 26, 2036.
The grant vests in two equal installments, with 50% vesting on September 30, 2026 and the remaining 50% vesting on December 31, 2026. Following this grant, Sweeny holds options on 1,284 shares directly. This is a compensation-related award rather than an open-market stock purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Sweeny Nicole
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options | 1,284 | $0.00 | -- |
Holdings After Transaction:
Stock Options — 1,284 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 1,284 options
Exercise price: $87.68 per share
Shares underlying options: 1,284 shares
+4 more
7 metrics
Options granted
1,284 options
Stock options award to director on June 26, 2026
Exercise price
$87.68 per share
Strike price for the 1,284 stock options
Shares underlying options
1,284 shares
Common stock underlying the options
Post-grant option holdings
1,284 options
Total options beneficially owned after the transaction
Vesting schedule first tranche
50% on September 30, 2026
Half of options vest on this date
Vesting schedule second tranche
50% on December 31, 2026
Remaining options vest on this date
Option expiration date
June 26, 2036
Last date to exercise this option grant
Key Terms
Stock Options, exercise price, expiration date, vesting, +1 more
5 terms
Stock Options financial
"security_title: "Stock Options""
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"conversion_or_exercise_price: "87.6800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-26T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vesting financial
"Options vest 50% on September 30, 2026, and 50% on December 31, 2026."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
FAQ
What did Monopar Therapeutics (MNPR) director Nicole Sweeny report in this Form 4?
Director Nicole Sweeny reported receiving a grant of 1,284 stock options. These options give her the right to buy Monopar Therapeutics common stock at a fixed price, as part of her compensation, rather than reflecting an open-market trade.
How many Monopar Therapeutics stock options were granted to Nicole Sweeny and at what price?
Nicole Sweeny was granted 1,284 stock options with an exercise price of $87.68 per share. This means she can purchase up to 1,284 shares of Monopar Therapeutics common stock at $87.68, regardless of the market price, once the options vest.
When do Nicole Sweeny’s Monopar Therapeutics stock options vest?
The options vest in two equal tranches: 50% on September 30, 2026 and 50% on December 31, 2026. Vesting means she gradually earns the right to exercise the options and buy shares at the fixed exercise price.
When do Nicole Sweeny’s Monopar Therapeutics stock options expire?
The stock options granted to Nicole Sweeny expire on June 26, 2036. After that expiration date, any unexercised options will lapse, and she will no longer be able to purchase shares under this specific grant.
How many Monopar Therapeutics options does Nicole Sweeny hold after this grant?
After this grant, Nicole Sweeny holds options on 1,284 shares of Monopar Therapeutics common stock directly. This figure reflects the total options from this award reported as beneficially owned following the transaction.